However, these differences were entirely due to significantly higher proportions of CD4+ T cells, lower proportions of CD8+ T cells and thus a higher CD4/CD8 ratio in the MS patients; there were no significant differences in lymphocyte distribution between ME/CFS cases and healthy controls. This evidence concerns the gene CD4 and myeloid sarcoma.